Results 231 to 240 of about 373,515 (298)
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source
The strategic distraction motive: addiction as attentional regulation under perceived insolubility. [PDF]
Alaye FA, Gelo O, Unterrainer HF.
europepmc +1 more source
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi +11 more
wiley +1 more source
HIV and Substance Use Reduction for Youth Experiencing Homelessness: Development and Usability Study. [PDF]
Santa Maria D +7 more
europepmc +1 more source
Cytisine-New Challenges of a Well-Known Drug in the Treatment of Nicotine Addiction. [PDF]
Bieniasz L +5 more
europepmc +1 more source
Stigma toward individuals with cannabis use disorder across age groups: associations with familiarity and sociodemographic characteristics. [PDF]
Basedow LA +4 more
europepmc +1 more source
Multilevel associations between skills use, engagement, and treatment outcome in self-guided internet-delivered dialectical behavior therapy for substance use disorders. [PDF]
Downie D, Daros AR, Wilks CR, Quilty LC.
europepmc +1 more source
A Daily Diary Study of Discrimination and Substance Use in Transgender and Nonbinary Adults. [PDF]
Basting EJ +4 more
europepmc +1 more source

